Spring offer! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Faster, slicker, customisable & ad free!Spring offer! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Go ad free today!Spring offer! Upgrade now at £2.99/m (40% OFF!)

Home
Hot Topics
UK
World
Gaza
Ukraine
Iran
Climate Crisis
Business
Football
Sport
Entertainment
Tech
Science

Gilead Sciences
Biotech
BioNTech
Topics

Advertisement

Gilead Sciences

Share

Top Latest Popular

🗞️ NEWSNOW ESSENTIALS | Support independent news discovery ad free at just £2.99/m!

🗞️ NEWSNOW ESSENTIALS | Support independent news discovery ad free at just £2.99 a month!

Investors heavily search Gilead Sciences, Inc. (GILD): Here is what you need to know Zacks 4d

Zacks 4d

Gilead’s New Drug Application for Yeztugo accepted by US FDA PMLiVE 6d

PMLiVE 6d

The Zacks analyst blog highlights Gilead Sciences, Merck and GSK Zacks 5d

Zacks 5d

Advertisement

Advertisement

Native son launches fellowship for black LGBTQ+ creators focused on HIV awareness Black Enterprise 3d

Black Enterprise 3d

Gilead and MSD’s once-weekly HIV pill meets primary endpoints in Phase III trials Clinical Trials Arena 09:18 Wed, 10 Jun

Clinical Trials Arena 09:18 Wed, 10 Jun

Can Gilead Sciences HIV franchise drive long-term growth? Zacks 20:20 Wed, 10 Jun

Zacks 20:20 Wed, 10 Jun

Advertisement

Advertisement

Latest

Thursday

Native Son Launches Fellowship For Black LGBTQ+ Creators Focused On HIV Awareness Black Enterprise 16:40 Thu, 18 Jun

Investors Heavily Search Gilead Sciences, Inc. (GILD): Here is What You Need to Know Zacks 15:00 Thu, 18 Jun

Wednesday

Game-changing HIV prevention drug must be available for $40 per year — everywhere Doctors Without Borders (Press Release) 21:10 Wed, 17 Jun

The Zacks Analyst Blog Highlights Gilead Sciences, Merck and GSK Zacks 09:46 Wed, 17 Jun

Tuesday

Gilead’s New Drug Application for Yeztugo accepted by US FDA PMLiVE 13:16 Tue, 16 Jun

FDA starts kicks off review of Gilead's weekly HIV pill pharmaphorum 12:45 Tue, 16 Jun

Gilead Sciences (GILD) Stock Falls Amid Market Uptick: What Investors Need to Know Zacks 00:07 Tue, 16 Jun

In the last month

U.S. FDA Accepts Gilead’s Application for Investigational Once-Weekly Oral Yeztugo, Potentially the First Long-Acting Pill for HIV Prevention Business Wire (Press Release) 21:37 Mon, 15 Jun

‘Remembrance work is future work’: Gilead commits $3M for HIV/AIDS education and preservation Local News Matters 01:09 Sat, 13 Jun

XLV, AMGN, TMO, GILD: ETF Inflow Alert Nasdaq 16:59 Fri, 12 Jun

Advertisement

Advertisement

Advertisement

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Biotech Biotech
Back to Industry Sectors Biotech
- GM Food GM Food
- AbbVie AbbVie
- Amgen Amgen
- Biogen Biogen
- BioNTech BioNTech
- Celltrion Celltrion
- Genentech Genentech
- Gilead Sciences
- Illumina Illumina
- Moderna Moderna